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Abtsract
When the first report of COVID-19 appeared in December 2019 from Wuhan, China, the 
world unknowingly perceived this as another flu-like illness. Many were surprised at the extreme 
steps that China had subsequently taken to seal Wuhan from the rest of the world. However, by 
February 2020, the SARS-CoV-2 virus, which causes COVID-19, had spread so quickly across the 
globe that the World Health Organization officially declared COVID-19 a pandemic. COVID-19 is 
not the first pandemic the world has seen, so what makes it so unique in Malaysia, is discussed to 
avoid a future coronacoma.
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COVID-19 is likely a zoonotic infection, 
which was transmitted from an unknown animal 
or environmental source to humans. It is now 
spreading via human-to-human transmission 
with an average basic reproductive rate (R0) of 
2.2. In other words, for each patient, 2.2 other 
individuals become infected (4). For comparison, 
the R0 for severe acute respiratory syndrome 
(SARS) was estimated at 3.0 and Middle East 
respiratory syndrome (MERS) was less than 1.0. 
Based on the epidemiological data from Wuhan, 
there are several notable differences between 
COVID-19 and SARS and MERS: i) case fatality 
rates are lower; ii) asymptomatic spread can 
occur and iii) fever is more frequently absent 
(5). Gastrointestinal complaints are uncommon 
among COVID-19 patients but loss of smell and 
loss of taste have been increasingly reported as 
early signs of infection. Severe acute respiratory 
illness (SARI) is a severe complication, and 
typical computed tomography (CT) features 
include ground-glass and consolidative opacities 
in the periphery (6). However, it must be borne 
in mind that SARI can also be a manifestation 
of respiratory illnesses with other infectious or 
non-infectious causes, which need to be ruled 
out before attributing the presence of SARI to 
COVID-19. 
The New Year with New Pandemic 
As of 26 March 2020, 171 countries 
have been affected by the coronavirus disease 
2019 or known as COVID-19 pandemic with 
467,866 infected patients and 20,845 deaths, 
representing a 4.5% mortality rate (1). While, at 
the time of writing, China is the most affected 
country, the rate of infection in China has 
slowed down significantly; however, this is not 
the case in Italy or the United States, which are 
the second and third most affected countries, 
respectively. Association of Southeast Asian 
Nations (ASEAN) countries, including Malaysia, 
have not been spared from COVID-19, although 
there have been fluctuations in the rate of 
infection demonstrated in the number of new 
cases and deaths reported in March 2020 
(Table 1) (2). Barely three months after the first 
reported case, many countries have ordered 
lockdowns, including Malaysia. The Malaysian 
government announced an initial movement 
restriction order on 16 March 2020 and an 
extension to mid-April. These measure have 
been enacted for good reason. The trend in new 
cases does not appear to have peaked yet for 
Malaysia or other ASEAN countries (Figure 1) 
(3), although there have been fluctuations in 
the death rates (Figure 2) (1) perhaps due to 
different critical care capacities and resources in 
these countries. 
Table 1. Number of new cases, new deaths, total cases and total deaths in South East Asia region 
(23–27 March 2020)
Date Country New cases New deaths Total cases Total deaths
27/3/2020 Malaysia 235 4 2031 23
27/3/2020 Thailand 91 1 1136 5
27/3/2020 Indonesia 103 20 893 78
27/3/2020 Singapore 26 0 594 2
27/3/2020 Brunei 7 0 114 0
26/3/2020 Malaysia 172 4 1796 19
26/3/2020 Thailand 111 0 1045 4
26/3/2020 Indonesia 104 3 790 58
26/3/2020 Singapore 10 0 568 2
26/3/2020 Brunei 3 0 107 0
25/3/2020 Malaysia 106 1 1624 15
25/3/2020 Thailand 107 0 934 4
25/3/2020 Indonesia 107 6 686 55
25/3/2020 Singapore 49 0 558 2
25/3/2020 Brunei 13 0 104 0
Source: European Centre for Disease Prevention and Control (2)
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Figure 1. Trajectory of the cumulative number of COVID-19 cases in a (a) linear scale and a (b) log scale. The 
increase in cumulative COVID-19 cases slowed between January 2020 and late February 2020. 
However, in early March 2020, the case trajectory in these five countries increased significantly 1(a). 
The increases were most stark from mid-March to 28 March 2020. The trend on the log-scale 1(b) 
indicates an exponential growth in cumulative cases for three countries—Thailand, Malaysia and 
Singapore—which was steeper between mid-January and mid-February and then reduced until early 
March. Overall, the log-scale 1(b) shows two trajectories: a lower trajectory (Brunei and Singapore) 
and a higher trajectory (Thailand, Malaysia and Indonesia) (3)
Halting the Spread with Rapid 
Diagnosis
A critical factor in slowing down the 
pandemic is the rapid diagnosis of new cases. 
Nucleic acid amplification tests, such as real-
time reverse transcription polymerase chain 
reaction (RT-PCR), provide the earliest and most 
accurate diagnosis, but they are costly and time 
consuming (7). Point-of-care tests, e.g. lateral 
flow assays for the detection of antibodies are 
more ideal in the field; however, these tests are 
of limited value due accuracy issues and the time 
required to obtain a diagnosis. Rapid antigen 
detection tests are still undergoing evaluation, 
and their efficacy is yet to be proven. Figure 3 
illustrates various tests being evaluated for 
COVID-19 and their diagnostic coverage from the 
acute phase to the convalescent phase. 
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Figure 2. (a) Trajectory for cumulative COVID-19-related deaths and (b) daily reported number of COVID-19-
related deaths. Thailand reported its first fatality in February 2020 and other countries (except for 
Brunei) began to report their first fatalities in mid-March 2020. Indonesia has had the largest number 
of fatalities (70 as of 27 March 2020), and the lowest were in Singapore (two deaths) and Brunei (no 
deaths). All countries reported fluctuating fatality numbers (except for Singapore) (1)
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high risk of exposure to the virus. Other than 
doctors at the frontlines, i.e. screening and 
critical care units, certain specialties may 
have increased risks of aerosolised exposure, 
including respiratory medicine; otolaryngology; 
ophthalmology; and dental services. Many 
non-urgent procedures have been cancelled or 
postponed, including non-emergency surgeries. 
Other than the aerosolised risk, the virus may 
contaminate the operating theatre during 
surgery. Many learned societies, including the 
Academy of Medicine of Malaysia, have started 
releasing statements and guidelines to assist 
their members (9). 
Meanwhile, grey areas and dilemmas exist 
without clear consensus, including guidelines 
for cancer patients on chemotherapy or those 
needing early surgical treatments. Furthermore, 
other issues should be addressed by hospitals 
through a management protocol or algorithm 
in place for frontline workers (10). For example, 
although many resources are being diverted 
to the frontlines and critical care, they will be 
inadequate during the height of the pandemic. 
Thus, there is an ethical but pragmatic challenge 
in the allocation of critical resources, such as 
intensive care unit (ICU) beds and ventilators 
(11). Age is often the sole criterion used for 
decision-making regarding ventilation, which 
can be morally difficult for people in general. 
Therefore, it is imperative that such decisions 
be made by a different team, and that the triage 
algorithm be reviewed regularly. 
The sources and accessibility of specimens 
are also critical for diagnosis. For upper 
respiratory specimens, the viral Ribonucleic 
acid yield from nasopharyngeal swabs seems to 
offer more accurate results than oropharyngeal 
swabs. The SARS-CoV-2 virus is also detectable 
in blood, urine and stool; such specimens are not 
as reliable for diagnosis but are important from 
the transmission point of view. Proper transport 
and handling of specimens is necessary to ensure 
the integrity of the viral RNA and, hence, the 
accuracy of the diagnostic test. Adherence to 
biosafety practices is essential, and any testing 
should be performed in appropriately equipped 
laboratories by staff trained in the relevant 
technical and safety procedures (World Health 
Organization, 2020) (8). Non-propagative 
diagnostic laboratory work should be conducted 
at a biosafety level 2 (BSL-2) facility, whereas 
propagative work, including virus culture and 
isolation, should be conducted at a containment 
laboratory with inward directional airflow 
(BSL-3). Virus isolation is not routine but 
necessary for characterisation and to support the 
development of vaccines and other therapeutic 
agents. 
Challenges to Healthcare Workers 
Until a vaccine is developed, healthcare 
workers who are in close contact with a suspect 
or a person under investigation (PUI) are at 
Figure 3. Diagnostic coverage of various available tests for COVID-19 from the acute phase to the convalescent 
phase 
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gatherings and any new symptoms. It is also 
important not to spread fake news to prevent 
panic and anxiety among the public. 
The most common psychological reactions 
to a pandemic are fear and anxiety-related 
symptoms, such as panic, worry and emotionally 
distress (17, 18). While these reactions are 
expected, they can be overwhelming to those 
with pre-existing mental health issues (19) 
and can lead the public to panic buy excessive 
amounts of food or health-related items, such 
as masks and hand sanitizer (18). According the 
most recent data on COVID-19 study among 
1,210 respondents from 194 cities in China (20), 
more than half of the respondents suffered 
moderate to severe psychological impacts; of 
those, 28.8% had moderate to severe anxiety, 
16.5% had moderate to severe depressive 
symptoms and 8.1% had moderate to severe 
stress levels. The majority were worried about 
their family members and they spent at least 
20 h per day at home (20). 
The psychological sequelae of the pandemic 
is the emergence of fear and anxiety not only 
due to the disease itself but also due to the 
disruption of daily activities, social isolation 
caused by the restricted movement order and 
financial burdens, especially among those with 
low-income levels (21). For healthcare workers, 
the pandemic is exposing them to long-term 
stressors, which could impact their wellbeing 
(22) and lead to burnout due to increased job 
demands (such as increased workload and role 
conflicts) and reduced job resources which lead 
to loss of workplace control and autonomy (23). 
Flattening the Curve
Although various antiviral agents 
such as avipiravir, ritonavir/lopinavir and 
hydroxychloroquine and other therapeutics, 
e.g. steroids and vaccines, are currently 
being considered to reduce the complications 
associated with COVID-19, including SARI and 
cytokine storms (12–14), the most cost-effective 
methods remain the public health approaches of 
contact tracing, isolation and social distancing. 
The COVID-19 pandemic is predicted to run 
a protracted course, and available healthcare 
resources are likely unsustainable; hence, we 
need to flatten the curve with lockdown measures 
(Figure 4) (15). However, the imposition of a 
lockdown needs to consider the sociocultural and 
economic factors of each country. 
Extreme measures, such as the Wuhan 
closure, will not work in many countries, 
including Malaysia. Instead, many countries 
may look to the South Korean model as a more 
suitable alternative. In South Korea, rapid testing 
to rule out COVID-19 has been the key to its 
success, along with using personal information 
to track the spread of the virus (16). In Malaysia, 
where social gathering is a norm, the initial 
days of the movement restriction order have 
been extremely difficult but necessary so that 
containment measures could be put into place 
quickly. The current mitigation phase is critical 
in order to create a small window of opportunity 
to break the transmission of the virus to the 
larger community. To do this, everyone should be 
transparent about their history of travels, mass 
Figure 4. Movement restriction is critical to battle the pandemic within healthcare system capacity (15)
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technology drivers of the present and the future 
to prevent and manage future epidemics and 
pandemics (Figure 5). Weaknesses have been 
identified and improvements are being explored 
before government action plans are made (25).
Another impact is on day-to-day work. 
Since many people are working from home, 
there is an urgent need to make better internet 
and software applications available for virtual 
meetings. From the healthcare perspective, tele-
medicine will play a greater role. Stable patients 
needing regular follow-ups, as well as patients 
in clinical trials, can be directed to tele-health 
services. These services could even be used for 
COVID-19 patients as a form of ‘forward triage’ 
before they arrive at emergency departments 
(26). 
In addition, this unique crisis has provided 
an opportunity to improve online education from 
home. Almost 5 million school students and 1.2 
million university students (including about 
130,000 international students) in Malaysia have 
been affected by closures (27). Distance learning 
is not new for Malaysians and can be traced back 
to the 1990s but times have changed with rapid 
advancements in technology and new teaching 
innovations. Due to COVID-19, online learning 
is no longer merely an option; however, adopting 
virtual technologies and ensuring the readiness 
Early mitigation and psychological crisis 
interventions are already in place in Malaysia. 
Several government and non-governmental 
agencies are offering psychological first aid 
to the public through tele-counselling and 
hotline services. These interventions should be 
continued even after the pandemic is over, as 
data has shown that those who are affected by 
a pandemic still have varying degrees of stress 
disorders even after the event ends or they 
recover from the disease (24). In addition, clear 
information about the disease and progress 
updates on the situation could reduce the 
psychological impacts of COVID-19 among the 
public (20).
Addressing the Socio-economic 
Impacts: Local Perspectives 
There is no doubt that the imposed 
movement control order in Malaysia will 
have adverse economic impacts; however, 
the government has been quick to respond 
by announcing an economic stimulus plan 
to weather this difficult period. Numerous 
important bodies, including the Academy of 
Sciences Malaysia, the Ministry of Health and the 
Ministry of Higher Education, are exploring the 
Figure 5. The Academy of Sciences Malaysia with assistance from Ministry of Health and the Monash 
University Malaysia, are exploring 10 technologies that will drive many aspects of Malaysia’s 
socio-economy, including preparation for future pandemics (25)
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